BioBuzz - Greater Philadelphia

Geography matters. Community matters. 𝙔𝙤𝙪 matter. Community is at the heart of everything that we do at BioBuzz. 🧡 Which is why we’re thrilled to showcase the community that continues to drive us to do what we do 𝗲𝗮𝗰𝗵 𝗮𝗻𝗱 𝗲𝘃𝗲𝗿𝘆 𝗱𝗮𝘆 with the launch of our Weekly Takeovers in Philly this September. Every week a new ambassador, community member, or ecosystem friend, will “takeover” our Greater Philadelphia showcase page. 🎉 They'll "own" the page for the week as they buzz about themselves, the incredible people around them, the work they’re doing and supporting, and the things that they’re passionate about. 𝗘𝘅𝗰𝗶𝘁𝗲𝗱? So are we. 𝗜𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝗲𝗱? Sign up today: https://lnkd.in/eiRdEKdc 𝗞𝗻𝗼𝘄 𝘀𝗼𝗺𝗲𝗼𝗻𝗲 𝘁𝗵𝗮𝘁'𝗱 𝗯𝗲 𝗮 𝗴𝗼𝗼𝗱 𝗳𝗶𝘁? TAG them below. 𝘗𝘭𝘦𝘢𝘴𝘦 𝘯𝘰𝘵𝘦 𝘵𝘩𝘢𝘵 𝘸𝘦 𝘬𝘪𝘯𝘥𝘭𝘺 𝘳𝘦𝘲𝘶𝘦𝘴𝘵 𝘵𝘩𝘢𝘵 𝘺𝘰𝘶 𝘭𝘪𝘷𝘦 𝘰𝘳 𝘸𝘰𝘳𝘬 𝘸𝘪𝘵𝘩𝘪𝘯 𝘵𝘩𝘦 𝘳𝘦𝘨𝘪𝘰𝘯 𝘢𝘯𝘥 𝘢𝘳𝘦 𝘸𝘪𝘵𝘩𝘪𝘯 𝘰𝘳 𝘴𝘶𝘱𝘱𝘰𝘳𝘵 𝘵𝘩𝘦 𝘭𝘪𝘧𝘦 𝘴𝘤𝘪𝘦𝘯𝘤𝘦𝘴. 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀? Message Cat, Annabel, Bryan or Joshua. #lifesciences #biotech #pharma #CGT #philly #community #biobuzz

🚨 BioBuzz Regional Round Up: Last week, Philadelphia’s biotech scene was buzzing with BioLabs for Advanced Therapeutics Philadelphia Investor Day and the Wharton Biotech Conference, showcasing exciting growth and innovation. Check out the full recap below! https://lnkd.in/eUfPfZp5 Also check out our weekly recap of the top stories form last week! 📈 FINANCIAL & OPERATIONAL NEWS >>BriaCell Therapeutics Corp. Therapeutics priced a $13.8M public offering >>COEPTIS, Inc Therapeutics & Z Squared Merger agreement signed >>West Pharmaceutical Services anticipates at least a $20M hit from tariffs >>PCI Pharma Services to acquire CA-based CDMO Ajinomoto Althea >>Palvella Therapeutics granted U.S. patent for QTORIN™ Rapamycin >>Wyss Foundation donates to establish Penn’s Orthoplastic Surgery Hub >>City of Philadelphia launches matching grant + commercialization support for life sciences >>$1.5M in early-stage research awarded by the NJ HEALTH CARE FOUNDATION INC 🧪 CLINICAL & COMMERCIAL WINS >>BriaCell Therapeutics Corp. reports 100% resolution of lung metastasis with Bria-OTS™ + accelerating Phase 3 trial enrollment >>Mineralys Therapeutics, Inc. Therapeutics publishes pivotal Phase 2 Advance-HTN results >>Aclaris Therapeutics, Inc. Therapeutics receives IND clearance for novel anti-TSLP/IL-4R antibody >>Children's Hospital of Philadelphia & Penn Medicine, University of Pennsylvania Health System use AI to pinpoint disease-causing variants >>Orchestra BioMed receives FDA Breakthrough Device Designation for AVIM therapy >>CHOP shows long-term gene therapy benefits for Hemophilia B >>CHOP’s Drs. Peranteau & Alameh win Abu Dhabi Global Health Week Innovation Award 💼 WORKFORCE MOVES >>Avantor CEO Michael Stubblefield to step down West Pharma announces leadership changes >>Actum Pharma expands exec team to support commercialization strategy Full newsletter: https://lnkd.in/eHCPRdYj

Delaware is making a bold statement in biotech. Merck has officially broken ground on a $1 billion R&D and manufacturing facility at Chestnut Run Innovation & Science Park, a transformative project developed by MRA Group. This next-generation campus will create 500+ new jobs and strengthen Delaware’s role as a key player in the Mid-Atlantic life sciences corridor. The new site will bring together research, development, and manufacturing under one roof—driving innovation and expanding Merck’s capacity to deliver life-saving medicines. For Delaware, it's a major win that reflects confidence in the state’s talent, infrastructure, and future as a biotech hub. Kudos to MRA Group for their vision and leadership in delivering yet another cutting-edge life science campus. 🔗 Read more via Delaware Online: https://lnkd.in/ePvwPeZj

Philadelphia's life sciences community has been hit by recent layoffs. If you're navigating your next step, you're not alone—this is your chance to restart stronger and more focused. Ready to reenter the industry? This is where it starts. NOW: Position Yourself 📅 Friday, May 30 🕰️ 8:30am to 1pm 📍 University City Science Center This free event isn’t just about finding your next job — it’s about elevating your personal brand, expanding your network, and getting the tools to move forward with confidence. What’s in store: 🔹 Resume reviews and real-time feedback 🔹 Tips to sharpen your professional story and online presence 🔹 Insights from industry insiders on where the jobs really are 🔹 Local support and connections that open doors Brought to you by Life Sciences Pennsylvania, Keystone LifeSci Collaborative, University City Science Center, and the The Chamber of Commerce for Greater Philadelphia. 👉 Register here: https://lnkd.in/ecJ2Pyvw 🗓️ Check out our PHL Life Science Event Calendar: https://lnkd.in/eNqeBKzF

🚨 Penn Medicine, University of Pennsylvania Health System Breaks Ground on $224M Proton Therapy Facility The $224 million proton therapy facility at Penn Presbyterian Medical Center, expected to open in late 2027. The Roberts Proton Therapy Center will be Penn’s fourth location offering proton therapy, an advanced form of radiation treatment that delivers highly precise doses to tumors while minimizing damage to surrounding healthy tissue. The new center will support seamless continuity of care as Penn prepares to upgrade its flagship Roberts Proton Therapy Center at the Perelman Center for Advanced Medicine—the busiest proton therapy facility in the world. Key additions at the new site include two ProteusONE proton systems, a new photon therapy treatment room using the TrueBeam system (coming online in fall 2025), and extended pediatric services in partnership with Children's Hospital of Philadelphia. The facility will also support expanded clinical trials and educational programs in radiation oncology. Penn’s hub-and-spoke model continues to enable expert planning and quality control across its proton therapy network, which includes sites in Philadelphia, Lancaster, and South Jersey. The initiative reflects Penn’s broader commitment to advancing cancer care through innovation, research, and system-wide access. Full press release: https://lnkd.in/e5Nnyrm5

One of B₊labs-located companies just took home a big win! 🏆 BioLattice was named 2025 Startup of the Year at BioLabs for Advanced Therapeutics Philadelphia’s #BioLabsInvestorDay—and we couldn’t be more excited for them.

Too many programs hit costly roadblocks moving from clinic to commercialization. Our friends at Kymanox are tackling that head-on. Check out this insightful article by Anna Jackson, M.S., PMP, on building a smarter, phase-appropriate strategy for combination product development. From container closure decisions to tech transfer pitfalls—this is a must-read for anyone navigating the #CombinationProducts landscape. Read it here: https://lnkd.in/e5uzFWDG

Another great event from BioStrategy Partners this time about CLIA Lab Dilemma for Startups. Happening on Tuesday May 20th from 3:30 to 6pm at The Center for Diagnostic Discovery in Horsham, Pa. Explore all the latest happenings in Greater Philadelphia’s life sciences scene — check out the BioBuzz Event Calendar! Link below 👇 https://lnkd.in/eNqeBKzF

Philadelphia has launched a unique SBIR/STTR matching grant program to support local life sciences companies that received federal grants in 2022 or later, offering up to $50,000 in services to help them commercialize their innovations. Eligible businesses must be based in Philadelphia and apply by June 20, 2025, to receive technical and business assistance tailored to their growth stage and market needs. Learn more here:     https://lnkd.in/ebzQuy7q     

Incredible to see Children's Hospital of Philadelphia’s (CHOP) global impact highlighted at Abu Dhabi Global Health Week. Congratulations to Drs. William Peranteau and Mohamad-Gabriel Alameh on receiving the inaugural 2025 Innovation Award for their pioneering work in prenatal gene editing. Proud moment for CHOP and Philadelphia!